Vidipha Central Pharmaceutical JSC (HOSE:VDP)
Vietnam · Delayed Price · Currency is VND 31,950
+450 (1.43%)
At close: Nov 2, 2026
HOSE:VDP Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
| 705,564 | 1,280,837 | 817,086 | 717,716 | 631,199 | - | |
Market Cap Growth | -33.44% | 56.76% | 13.84% | 13.71% | - | - |
Enterprise Value | 446,409 | 1,171,491 | 757,237 | 883,225 | 796,708 | - |
Last Close Price | 31950.00 | 43529.00 | 26621.04 | 21889.24 | 19715.24 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
PE Ratio | 10.67 | 20.07 | 11.38 | 8.95 | 8.58 | - |
Forward PE | - | 14.65 | 14.65 | 14.65 | 14.65 | - |
PS Ratio | 0.70 | 1.30 | 0.87 | 0.70 | 0.63 | - |
PB Ratio | 0.89 | 1.71 | 1.09 | 0.98 | 1.01 | - |
P/TBV Ratio | 0.95 | 1.82 | 1.15 | 1.04 | 1.05 | - |
P/FCF Ratio | 2.58 | 5.90 | 38.70 | 14.68 | - | - |
P/OCF Ratio | 2.43 | 5.38 | 23.69 | 6.60 | 57.10 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
EV/Sales Ratio | 0.44 | 1.19 | 0.81 | 0.87 | 0.79 | - |
EV/EBITDA Ratio | 3.93 | 10.44 | 6.76 | 6.98 | 7.15 | - |
EV/EBIT Ratio | 5.21 | 14.16 | 9.25 | 8.91 | 8.79 | - |
EV/FCF Ratio | 1.63 | 5.39 | 35.87 | 18.06 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
Debt / Equity Ratio | 0.24 | 0.26 | 0.34 | 0.37 | 0.54 | - |
Debt / EBITDA Ratio | 1.67 | 1.77 | 2.31 | 2.16 | 3.02 | - |
Debt / FCF Ratio | 0.69 | 0.91 | 12.24 | 5.59 | - | - |
Net Debt / Equity Ratio | -0.33 | -0.31 | -0.08 | -0.08 | 0.06 | -0.43 |
Net Debt / EBITDA Ratio | -2.28 | -2.09 | -0.52 | -0.47 | 0.35 | -2.32 |
Net Debt / FCF Ratio | -0.95 | -1.08 | -2.76 | -1.22 | -0.71 | -2.95 |
Asset Turnover | - | 0.88 | 0.84 | 0.93 | - | 1.13 |
Inventory Turnover | - | 2.31 | 2.19 | 2.35 | - | 4.89 |
Quick Ratio | 1.82 | 1.73 | 1.51 | 1.53 | 1.07 | 5.28 |
Current Ratio | 2.62 | 2.52 | 2.47 | 2.42 | 1.93 | 6.98 |
Return on Equity (ROE) | - | 8.50% | 9.68% | 11.81% | - | 16.63% |
Return on Assets (ROA) | - | 4.61% | 4.61% | 5.64% | - | 8.77% |
Return on Invested Capital (ROIC) | 11.38% | 10.46% | 9.53% | 11.83% | 18.77% | 23.45% |
Return on Capital Employed (ROCE) | 10.80% | 11.00% | 10.90% | 13.50% | 14.50% | 15.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '08 Dec 31, 2008 |
Earnings Yield | 9.37% | 4.98% | 8.79% | 11.18% | 11.65% | - |
FCF Yield | 38.72% | 16.96% | 2.58% | 6.81% | -8.54% | - |
Dividend Yield | 7.83% | - | 6.76% | - | - | - |
Payout Ratio | 22.74% | 86.17% | 63.91% | 29.89% | 65.70% | 50.28% |
Buyback Yield / Dilution | - | - | -9.33% | - | -180.50% | -9.02% |
Total Shareholder Return | 7.83% | - | -2.58% | - | -180.50% | -9.02% |